Senile Osteoporotic Fractures Cohort Study（SOFCS）

Status Recruiting

Clinical Trial Summary

Osteoporotic fracture is one of the main causes of disability and death in elderly patients. Specific disease cohort study is an important basis for accurate prevention and treatment of senile osteoporotic fractures. Investigators plan to collect and manage the baseline and clinical information of more than 2000 elderly patients with osteoporotic fractures after surgery through the platform of special disease collaborative prevention and treatment system and medical record database of Suzhou Municipal Hospital in two years, and carry out short-term and long-term follow-up observation.

Clinical Trial Description

Osteoporotic fracture is one of the main causes of disability and death in elderly patients. Compared with patients with no history of fractures, the risk of a second fracture after an initial fracture doubled, with a fatality rate of up to 34.8%. There has been a lot of progress in the diagnosis and treatment of osteoporotic fractures in the elderly. However, there are few reports on the diagnosis and treatment of osteoporotic fractures in the elderly after surgery. Based on previous studies, it is found that the re-fracture after operation of osteoporotic fracture in the elderly is not only directly caused by the fall, but also caused by the interaction of multiple risk factors including environmental factors, physiological factors and neuroskeletal musculoskeletal system. Therefore, it is of great significance to break the traditional diagnosis and treatment mode, improve the diagnosis and treatment effect, and save medical resources to carry out research on the disease characteristics, rules and risk warning after senile osteoporotic fracture operation. Specific disease cohort study is an important basis for accurate prevention and treatment of senile osteoporotic fractures. Investigators plan to collect and manage the baseline and clinical information of more than 2000 elderly patients with osteoporotic fractures after surgery through the platform of special disease collaborative prevention and treatment system and medical record database of Suzhou Municipal Hospital in two years, and carry out short-term and long-term follow-up observation. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05848167
Study type	Observational
Source	Suzhou Municipal Hospital
Contact	Hao Y feng, doctor
Phone	13913109339
Email	13913109339@163.com
Status	Recruiting
Phase
Start date	July 15, 2021
Completion date	July 14, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06367582` - SPINE BONE CEMENTS OUTCOMES
Completed	`NCT02922478` - Role of Comorbidities in Chronic Heart Failure Study
Not yet recruiting	`NCT02223572` - Secondary Fracture Prevention in Patients Who Suffered From Osteoporotic Fracture	N/A
Not yet recruiting	`NCT05738785` - Risk of Osteoporotic Fracture in Home Care Patients in Turkey
Recruiting	`NCT05489952` - Iron Supplementation for Geriatric Hip Fractures	Phase 4
Enrolling by invitation	`NCT05018637` - Efficacy of WJ-derived Mesenchymal Stem Cells in Combination With Parathyroid Hormone for Vertebral Compression Fracture	Phase 2
Completed	`NCT02972424` - PTH(1-34) and Pelvic Fracture Healing - a Randomized Controlled Trial	Phase 2
Recruiting	`NCT02247011` - A 5-Year Follow-up Study Investigating Factors Associated With Osteoporotic Fracture in Chinese Postmenopausal Women	N/A
Completed	`NCT04911946` - Training of Orthopedic Residents in OP Treatment
Completed	`NCT02753283` - Preventing Osteoporosis Using Denosumab	Phase 4
Recruiting	`NCT02148848` - Short-term Functional Recovery Between Early- and Late Bisphosphonate Treatment Following Hemiarthroplasty	Phase 4
Terminated	`NCT01532076` - Effectiveness of Adipose Tissue Derived Mesenchymal Stem Cells as Osteogenic Component in Composite Grafts	Phase 2
Completed	`NCT00594295` - Follow-up of Bone Quality in Long-Term Bone Marrow Transplant Survivors	N/A
Not yet recruiting	`NCT05866029` - Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture	N/A
Enrolling by invitation	`NCT03994094` - Three Year Evaluation of a Cohort of Patients Presenting Osteoporotic Fractures
Recruiting	`NCT05388227` - Pole Walking Intervention in Retirement Communities
Active, not recruiting	`NCT03642808` - Optimisation of Falls Prevention After Low-energy Osteoporotic Fractures: Feasibility Study	N/A
Recruiting	`NCT05424536` - Cortical Bone Assessment Using Ultrasonic Guided Waves: Towards a Robust Clinical Measurement
Not yet recruiting	`NCT05943600` - An Assessment of Treatment Adherence of Osteoporosis Patients From a Biopsychosocial Perspective
Completed	`NCT05721898` - Assessment of Cortical Bone Mechanics Technology (CBMT) Fracture Discrimination Capability

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.